Curis Inc SEC filings CRIS
Curis Inc has 1,006 filings in SEC EDGAR's recent list, going back to Jun 3, 2005. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Nov 2, 2026 | Nov 18, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 23, 2026 | Nov 18, 2026 |
| DEF 14A | Proxy statement | Jun 5, 2026 | Jun 25, 2026 |
| PRE 14A | Preliminary proxy statement | May 22, 2026 | Jun 25, 2026 |
| DEF 14A | Proxy statement | Apr 21, 2026 | May 19, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | May 19, 2026 |
| DEF 14A | Proxy statement | Feb 19, 2026 | Mar 17, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 9, 2026 | Mar 17, 2026 |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEF 14A | Proxy statement | Apr 10, 2025 | May 20, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 31, 2025 | May 20, 2025 |
| DEFA14A | Additional proxy material | Apr 10, 2024 | — |
| DEF 14A | Proxy statement | Apr 10, 2024 | May 21, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 29, 2024 | Apr 10, 2024 |
| DEF 14A | Proxy statement | Aug 18, 2023 | Sep 26, 2023 |
| PRE 14A | Preliminary proxy statement | Aug 4, 2023 | Sep 26, 2023 |
| DEFA14A | Additional proxy material | Apr 11, 2023 | — |
| DEF 14A | Proxy statement | Apr 11, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 13, 2022 | — |
| DEF 14A | Proxy statement | Apr 13, 2022 | May 26, 2022 |
| DEFA14A | Additional proxy material | Apr 14, 2021 | — |
| DEF 14A | Proxy statement | Apr 14, 2021 | May 27, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 2, 2021 | May 27, 2021 |
| DEFA14A | Additional proxy material | Apr 22, 2020 | — |
| DEF 14A | Proxy statement | Apr 22, 2020 | Jun 4, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2020 | Jun 4, 2020 |
| DEFA14A | Additional proxy material | Apr 11, 2019 | — |
| DEF 14A | Proxy statement | Apr 11, 2019 | May 23, 2019 |
| PRE 14A | Preliminary proxy statement | Mar 29, 2019 | May 23, 2019 |
| DEFA14A | Additional proxy material | Apr 3, 2018 | — |
| DEF 14A | Proxy statement | Apr 3, 2018 | May 15, 2018 |
| PRE 14A | Preliminary proxy statement | Mar 23, 2018 | May 15, 2018 |
| DEFA14A | Additional proxy material | May 4, 2017 | — |
| DEFA14A | Additional proxy material | Apr 4, 2017 | — |
| DEF 14A | Proxy statement | Apr 4, 2017 | May 16, 2017 |
| DEFA14A | Additional proxy material | Apr 5, 2016 | — |
| DEF 14A | Proxy statement | Apr 5, 2016 | May 17, 2016 |
| DEFA14A | Additional proxy material | Apr 15, 2015 | — |
| DEF 14A | Proxy statement | Apr 15, 2015 | May 27, 2015 |
| DEFA14A | Additional proxy material | Apr 9, 2014 | — |
| DEF 14A | Proxy statement | Apr 9, 2014 | May 21, 2014 |
| DEFA14A | Additional proxy material | Apr 16, 2013 | — |
| DEF 14A | Proxy statement | Apr 16, 2013 | May 30, 2013 |
| PRE 14A | Preliminary proxy statement | Apr 5, 2013 | May 30, 2013 |
| DEFA14A | Additional proxy material | Apr 13, 2012 | — |
| DEF 14A | Proxy statement | Apr 13, 2012 | May 30, 2012 |
| DEFA14A | Additional proxy material | Apr 19, 2011 | — |
| DEF 14A | Proxy statement | Apr 19, 2011 | Jun 1, 2011 |
| DEFA14A | Additional proxy material | Apr 16, 2010 | — |
| DEF 14A | Proxy statement | Apr 16, 2010 | Jun 3, 2010 |
| DEFA14A | Additional proxy material | Apr 17, 2009 | — |
| DEF 14A | Proxy statement | Apr 17, 2009 | Jun 3, 2009 |
| DEF 14A | Proxy statement | Apr 11, 2008 | Jun 3, 2008 |
| DEF 14A | Proxy statement | Apr 13, 2007 | Jun 6, 2007 |
| DEF 14A | Proxy statement | Apr 13, 2006 | Jun 1, 2006 |
Showing 55 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CRIS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lexington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1108205
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.